Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction

PUSUROGLU H., AKGUL O., ERTURK M., Uyarel H., BULUT U., AKKAYA E., ...Daha Fazla

CORONARY ARTERY DISEASE, cilt.25, sa.7, ss.558-564, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 7
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1097/mca.0000000000000142
  • Dergi Adı: CORONARY ARTERY DISEASE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.558-564
  • Anahtar Kelimeler: myocardial infarction, primary angioplasty, soluble CD40 ligand, ACUTE CORONARY SYNDROMES, ARTERY-DISEASE, CLINICAL-IMPLICATIONS, RISK, ATHEROSCLEROSIS, PATHOGENESIS, INFLAMMATION, MECHANISMS, BIOMARKERS, EVENTS
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

Objectives The aim of this study was to evaluate the prognostic value of soluble CD40 ligand (sCD40L) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing a primary percutaneous coronary intervention (PCI).